Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.

This Fund Manager Rating is based on the Citywire Long Only ratings methodology

Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated

Leefin Lai

Leefin Lai

Citywire Rating: Not Rated

2017

  • FRated Plus in Feb 2017
  • MRated A in Mar 2017
  • ARated A in Apr 2017
  • MRated AA in May 2017
  • JRated A in Jun 2017
  • JRated A in Jul 2017
  • ARated A in Aug 2017
  • SRated Plus in Sep 2017
  • ORated Plus in Oct 2017
  • NNot rated in Nov 2017
  • DNot rated in Dec 2017

Performance

Equity - Pharmaceuticals & Health Care
over : 30/11/2016 - 30/11/2017

Total Return

Month by Month Performance

Quarterly Performance

to 30/09/2017 Annual Q1 Q2 Q3 Q4
2017 9.8% 6.3% 2.8%
2016 -10.2% -10.8% 4.6% 2.9% -6.5%
2015 6.9% 9.3% 3.7% -12.5% 7.8%
2014 27.0% 6.1% 4.5% 5.7% 8.3%
2013 47.1% 15.4% 3.7% 11.5% 10.3%
Citywire Discovery Source: Citywire Discovery Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated)..Portions of the information contained on this page was derived by Citywire Financial Publishers Ltd using content supplied by Lipper, A Reuters Company.